Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.10), $0.05 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• Encompass Health Corporation (EHC) files mixed shelf